New Contrast Agent Could Improve Colon Cancer Detection

A subsidiary of GE Healthcare is developing a contrast agent that can help detect nearly invisible colon cancer polyps, according to a report by News Medical.

Advertisement

 

In addition to the mushroom-shaped polyps picked up in colonoscopies, there are also flat polyps in the colon that are far more difficult to detect visually.

 

GE Healthcare’s GE-137 is a targeted contrast agent that seeks out the cancer once it is injected by needle in the patient’s arm. Under a strong red light, the contrast agent changes the color of the light at the site of the cancer so it can be detected by a specially equipped camera.

 

Read the News Medical report on colon cancer detection.

 

Related Articles on Colon Cancer Detection:

Nearly One-Third of Target Population Unscreened for Colon Cancer

Study: 42% of Polyps Missed in Colonoscopies With Poor Bowel Preps

Study: New Biopsy Needle Accurately Diagnoses Cancers of GI Tract


Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.